Latest News and Press Releases

MindRank, artificial intelligence (AI)-empowered drug discovery company, announced FPI in Phase III Trial of an Oral GLP-1 Receptor Agonist MDR-001.

Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036, supported by anti-VEGF therapies and AI-enabled imaging.

Validfor raises $1.2M pre-seed to build AI agentic digital validation for Pharma/Biotech/MedTech GxP compliance.

Global Pharmaceutical Packaging Manufacturer Selects Kneat for Digital Validation

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit focused on accelerating a cure for type 1 diabetes (T1D), announced the release of a...

BCC Research, “Contract Manufacturing of Medical Devices: Global Markets” is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030.

Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications Press releaseCopenhagen — February 10, 2026 —...

The global Anti-obesity Drugs market is projected to grow at a CAGR of 24.2% to reach US$195.99 billion by 2036.

GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026...

The acquisition expands scalable trial operations across real-world care settings